Insight Molecular Diagnostics Inc
(IMDX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -64,097 | -28,212 | -14,412 | -3,919 | -29,932 |
| Depreciation Amortization | 4,261 | 2,999 | 1,741 | 447 | 918 |
| Income taxes - deferred | -9,261 | -9,358 | -9,358 | -7,564 | -1,254 |
| Accounts receivable | -1,229 | -824 | -817 | -499 | -182 |
| Accounts payable and accrued liabilities | -1,348 | -1,592 | -766 | 405 | 848 |
| Other Working Capital | -2,203 | -582 | -1,468 | -1,206 | 1,982 |
| Other Operating Activity | 37,936 | 8,693 | 7,187 | 2,501 | 1,640 |
| Operating Cash Flow | $-35,941 | $-28,876 | $-17,893 | $-9,835 | $-25,980 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,247 | -1,846 | -1,452 | -842 | -1,227 |
| Net Acquisitions | -11,714 | -11,714 | -11,714 | -7,430 | -6,514 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -4,000 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -7 |
| Investing Cash Flow | $-13,961 | $-13,560 | $-13,166 | $-8,272 | $-11,748 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 1,141 |
| Debt Repayment | -1,534 | -1,252 | -834 | -416 | -446 |
| Common Stock Issued | 83,202 | 83,190 | 74,168 | 70,490 | 22,250 |
| Common Stock Repurchased | -239 | -239 | -37 | N/A | -14 |
| Other Financing Activity | -3,065 | -3,066 | -2,879 | -203 | -132 |
| Financing Cash Flow | $78,364 | $78,633 | $70,418 | $69,871 | $22,799 |
| Beginning Cash Position | 8,843 | 8,843 | 8,843 | 8,843 | 23,772 |
| End Cash Position | 37,305 | 45,040 | 48,202 | 60,607 | 8,843 |
| Net Cash Flow | $28,462 | $36,197 | $39,359 | $51,764 | $-14,929 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,941 | -28,876 | -17,893 | -9,835 | -25,980 |
| Capital Expenditure | -2,247 | -1,846 | -1,452 | -842 | -1,227 |
| Free Cash Flow | -38,188 | -30,722 | -19,345 | -10,677 | -27,207 |